The ability of circBACH1 to sponge miR-217, leading to the upregulation of G3BP2 expression, highlights a potential therapeutic target for combating PTX resistance and BC progression through the circBACH1/miR-217/G3BP2 axis. This evidence concerns the gene G3BP2 and breast cancer.